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Metabolic syndrome, as manifested by visceral obesity, hypertension, insulin resistance, and dyslipidemia, is reaching epidemic
proportions in the Western World, speciﬁcally the United States. Epidemiologic studies suggest that the increased prevalence of
metabolic syndrome directly correlates with an increase in the consumption of fructose, mainly in the form of high-fructose corn
syrup. This inexpensive alternative to traditional sugar has been increasingly utilized by the food industry as a sweetener since
the 1960s. While augmented caloric intake and sedentary lifestyles play important roles in the increasing prevalence of obesity,
the pathogenesis of hypertension in metabolic syndrome remains controversial. One intriguing observation points to the role of
salt in fructose-induced hypertension. Recent studies in rodents demonstrate that increased dietary fructose intake stimulates salt
absorption in the small intestine and kidney tubules, resulting in a state of salt overload, thus setting in motion a cascade of events
that will lead to hypertension. These studies point to a novel interaction between the fructose-absorbing transporter, Glut5, and
the salt transporters, NHE3 and PAT1, in the intestine and kidney proximal tubule. This paper will focus on synergistic roles of
fructose and salt in the pathogenesis of hypertension resulting from salt overload.
1. MetabolicSyndrome and Increased
Fructose Consumption
The increased incidence of metabolic syndrome, as man-
ifested by obesity, insulin resistance, hypertension, and
cardiovascular ailment has brought the question of modern
lifestyles and diets to the forefront of public debate. Numer-
ous discussions and investigations have focused on whether
sedentary lifestyles, contemporary changes in diet, or both
are responsible for the rise in obesity found throughout
Westernized cultures.
Proponents of the diet change argument point to the fact
that our current diet is comprised of unbalanced nutrients,
mainly too many carbohydrates, and has a total caloric
intake that is well above our daily needs [1, 2]. Some
anthropologists who subscribe to this view believe that
early humans (hominids) consumed a signiﬁcant amount
of meat and possibly obtained most of their food from
hunting [3]. Competing hypotheses within the same camp
suggest that early humans may have consumed a plant-based
diet in general [4], or that hunting and gathering possibly
contributedequallytotheirdiet[5].Ther elati v epr o portions
of plant and animal foods in the diets of early humans
(Paleolithic) probably varied between regions. For instance,
hunter-gatherers in tropical regions such as Africa probably
consumed a plant-based diet, while populations in colder
regions such as Northern Europe most likely obtained most
of their food from meat [6]. A plant-based diet contains a
large amount of carbohydrates, whereas a meat-based diet is
low in carbohydrates and high in protein.2 International Journal of Nephrology
Fructose is a monosaccharide and one of the three most
important blood sugars, along with glucose and galactose
[7]. It is predominantly metabolized in the liver and plays
an essential role in vital metabolic functions in the body,
including glycolysis and gluconeogenesis [8]. Fructose is
naturally present in fruits such as apples, peaches, pears,
and bananas, as well as in honey. Although it was present
in the diets of early humans in the form of fruits, several
studies indicate that the consumption of dietary fructose
has skyrocketed during the last four decades. This is mostly
due to the marked increase in the intake of high fructose
corn syrup, a common sweetener used throughout the food
industry. It has been shown that augmented absorption
of fructose in the intestine disrupts glucose metabolism
in the liver and leads to an enhanced rate of triglyceride
synthesis.
Current data suggests that life originated in a saltwater
environment billions of years ago and eventually migrated
to dry land where both salt and water are not as plentiful.
As a result, this migration required organisms to develop
physiological adaptations and evolve organs to conserve and
recover salt and water in their bodies. It is to be noted that
the ﬂora available on land are not only sodium deﬁcient
but are also potassium rich. Thus, human physiology
evolved in a sodium deﬁcient, but potassium rich paradigm.
Unfortunately, enhanced salt consumption has been the
hallmark of dietary changes in Westernized cultures. Not
surprisingly, the changes from a low-sodium diet to a diet
high in sodium resulted in a steep rise in hypertension,
especially in populations where salt and water have been
traditionally scarce. This is supported by studies showing
that salt intake, as well as hypertension, was lowest in many
rural and under-developed areas in Africa relative to the
industrialized world [9–11].
2.IncreasedDietaryFructose,High-Salt
Diet, andHypertension
A recent report by the American Heart Association under-
scored its concern over the shift in daily diet intake by
indicating that Americans are consuming an average of 22
teaspoons of sugar each day [11]. More alarming is the
dietary intakes in teens between the ages 14 and 18, who
consume an astonishing 34 teaspoons of added sugar a day
[11]. Most of the added sugar comes from soft drinks and
candy-a staggering 355 calories, and is predominantly in the
form of fructose.
In addition to fructose, Americans consume a signiﬁcant
amount of salt, well above what is needed for normal
functioning of heart, kidney, and other organs. The National
Academy of Sciences considers amounts of salt ranging from
1,100 to 3,300milligrams per day safe and adequate for
healthy adults. But the typical American consumes 6 to 8
times that amount, much of it “hidden” in the processed
foods that constitute more than half of what Americans eat.
The Center for Disease Control (CDC) warns that increased
salt intake is signiﬁcantly raising the risk of hypertension,
cardiovascular disease, and kidney failure [11].
It is universally agreed that metabolic syndrome and
the obesity epidemic are the result of increased caloric
intake coupled with decreased physical activity. However,
the pathogenesis of hypertension in metabolic syndrome
remains less well understood. Possibilities such as enhanced
insulin secretion, activation of the renin angiotensin system,
elevated serum uric acid, obesity, and decreased nitric oxide
generation by vascular endothelial cells have been proposed,
and evidence in support of their role in the pathogenesis
of hypertension has been presented [14–16]. Some studies
point to sodium retention, impairment of endothelial nitric
oxide production, or sympathetic activation as contributing
factors to the generation of hypertension in metabolic
syndrome [15, 16]. A recent report suggested that increased
expressionofangiotensinIItype1receptorinmesangialcells
plays an important role in the pathogenesis of hypertension
in metabolic syndrome [17], while other studies have impli-
cated stress response, with an underlying abnormality in the
enzyme 11beta-hydroxysteroid dehydrogenase (HSD1), as a
contributing factor [18].
The steep increase in fructose consumption directly cor-
relates with the increased incidence of metabolic syndrome
and prevalence of hypertension in developed countries [19].
In rats, mice, and dogs, increased dietary fructose intake
for several weeks has been shown to recapitulate many
parameters of metabolic syndrome, including hypertension,
insulin resistance, and hyperlipidemia [13, 19–27]. Indeed,
increased dietary fructose intake has been shown to cause
hypertension in rats, as early as 2 to 4 weeks after the start of
theexperiment[19–23].Therearenotablespeciesdiﬀerences
with regard to the rapidity of the onset of hypertension in
mammalians: While dogs develop hypertension as early as
2w e e k s ,i tt a k e sm o r et h a n1 0w e e k sf o rm i c et od e v e l o p
hypertension when fed increased dietary fructose [13, 25–
27].
Hypertension is a complex, multifactorial disorder, and
attributing its etiology to a single factor is too simplistic.
One major factor, however, which is essential to the under-
standing of blood pressure regulation and hypertension, is
altered salt absorption in the kidney [28–31]. Several studies
have implicated enhanced salt intake and absorption in the
kidney, along with high insulin levels, as important factors in
the pathophysiology of hypertension in metabolic syndrome
[32–34]. It is worth mentioning that most of the high salt-
containing (e.g., processed foods) diets are also deﬁcient
in potassium and adequate potassium intake is shown to
improve hypertension control [35].
Given the independent roles of increased dietary fructose
and salt in causing hypertension and given the increased
consumption of both fructose and salt in our daily diet, the
question needs be asked as to whether the increased dietary
fructose and salt intake have any synergistic eﬀect on blood
pressure elevation. Recent studies have shed new light on the
role of dietary fructose on salt absorption in the intestine or
kidney, which will be discussed below.
Given the important role of fructose and salt in the
pathogenesis of hypertension, a review of the literature
on the pathways and molecules mediating their absorption
in the intestine and kidney provides a timely discourse.International Journal of Nephrology 3
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Figure 1: Localization of Glut2 and Glut5 in jejunum and their regulation in response to increased dietary fructose intake. Glut5 which only
transports fructose but not glucose resides in the apical membrane at basal state (a) and is activated in response to increased dietary fructose
intake (b). Glut2 which can transport both glucose and fructose is expressed in the cytoplasm and on basolateral membrane at basal state
(a) and is recruited to the apical membrane in the presence of increased dietary fructose or glucose intake.
Further,the newlyidentiﬁed roleof fructosein activating salt
absorption in the intestine and kidney will be discussed.
3. Fructose Absorption in the Small
IntestineandKidney ProximalTubule:
Glut2versus Glut5
Fructose is absorbed in the small intestine and kidney
proximal tubule, predominantly via Glut5 and Glut2, which
are members of facilitative carbohydrate transporting family
[36–41]. Glut5 is exclusively transporting fructose while
Glut2 is capable of transporting both glucose and fructose
[36–41]. Glut5 is expressed on the apical membrane of
enterocytes; whereas, Glut2 is located intracellularly and on
the basolateral membrane at basal state. Both Glut5 and
Glut2 are upregulated in response to high levels of dietary
fructose intake; however, in the presence of elevated fructose
or glucose intake it is Glut2 that is recruited from the
basolateral to the apical membrane while Glut5 remains in
its original apical position [39–41]. Figures 1(a) and 1(b)
depicts the localization and role of Glut2 and Glut5 in
fructose absorption in jejunum at basal state (a) and in
response to increased dietary fructose intake (b).
While it has been proposed that Glut2 is a major glucose-
and fructose-absorbing transporter [36, 37], there is little
evidence in support of fructose malabsorption in Glut2
deﬁcient mice. On the other hand, Glut5 deletion abolishes
the absorption of fructose in the small-intestine and causes
a profound fructose malabsorption in Glut5 knock-out mice
[42]. In addition to the small intestine, Glut5 is abundantly
expressed in the proximal tubule, speciﬁcally in the S3
segment [41].
4. SaltAbsorption in the SmallIntestineand
Kidney ProximalTubule
The absorption of salt (NaCl) in the small intestine is
mediated via the Na+/H+ exchanger NHE3 (Slc9a3) working
in parallel with Cl−/HCO3
− exchangers DRA (Slc26a3) and
PAT1 (Slc26a6) [43–57]. Figure 2 depicts the localization
of salt absorbing transporters in the small intestine (a)
and kidney proximal tubule (b). As shown, SLC26A6
(human)/Slc26a6 (mouse), also known as PAT1 (Putative
Anion Transporter 1) is expressed on the apical membranes
of upper villous epithelium in the small intestine and the
kidneyproximaltubule[46–54].PAT1,whichcanfunctionin
vivo as both a Cl−/HCO3
− and Cl−/oxalate exchanger, plays
important roles in the absorption of salt and secretion of
bicarbonate in the small intestine and in chloride absorption
in the kidney proximal tubule [46–54]. DRA (Slc26a3) is
expressed on the apical membrane of mid to lower villous
epithelium in the small intestine and the upper villous
epithelium of large intestine [55, 56] where it plays an essen-
tial role in chloride absorption in both locations. Human
mutations rendering DRA inactive results in chloride-losing
diarrhea [55]. Recent studies indicate that genetic deletion of
DRA recapitulates the phenotype of chloride losing diarrhea
in mice as well [56].
5. Fructose StimulatesSalt
Absorption in PerfusedJejunum:
Interaction of Glut5with PAT1
Recent studies have unmasked a remarkable interaction
between fructose and salt absorption in the small intestine.
These studies demonstrated that in vivo perfusion of the4 International Journal of Nephrology
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Figure 2: Localization of salt absorbing transporters in the small intestine (a) and kidney proximal tubule (b). NHE3: sodium hydrogen
exchanger3: SLC9A3; PAT1: putative anion transporter 1: SLC26A6; DRA: down regulated in adenoma: SLC26A3.
proximal jejunum in WT mice resulted in a signiﬁcant
increase in ﬂuid absorption in the jejunum [13]. However,
the stimulatory eﬀect of fructose on salt was signiﬁcantly
blunted in mice deﬁcient in PAT1−/− [13]. Contrary to the
b l u n t e dr e s p o n s es e e ni nt h ej e j u n u mo fP A T 1k om i c e ,
luminal fructose elicited a very robust stimulatory eﬀect on
salt absorption in the jejunum of DRA ko mice (Seidler
and Soleimani, unpublished data), indicating that DRA
is not activated by fructose. The fructose-stimulated salt
absorptioninjejunumwascompletelydependentonluminal
chloride or sodium and was abrogated in NHE3 ko mice
(Seidler and Soleimani, unpublished data). Taken together,
these studies strongly suggest that fructose-stimulated salt
absorption is mediated via PAT1 and NHE3.
Recent studies have unmasked the minimum molecular
machinery that mediates fructose-stimulated salt absorption
in the small intestine. In vivo perfusion of the jejunum
from Glut 5−/− mice indicated that the stimulatory eﬀect
of fructose on salt absorption was completely blocked [42],
indicating that the presence of Glut5 is essential for fructose-
stimulatedsaltabsorptionintheintestine.Giventheessential
roles of NHE3, and PAT1 in enhanced salt absorption in the
intestine (above) it is speculated that Glut5, NHE3 and PAT1
are the major players in fructose-stimulated salt absorption.
Figure 3 depicts the role of fructose and Glut5 in fructose
absorption and fructose-stimulated salt absorption in the
small intestine.
6. Effect of IncreasedDietaryFructose on
the Expressionof Glut5, PAT1, and NHE3in
the Small Intestine
In addition to the acute stimulatory eﬀect of fructose
on salt absorption in perfused jejunum, balanced studies
demonstrated additional mechanisms through which fruc-
tose stimulates salt absorption. These studies indicated that
animals that were fed 60% fructose diet for two weeks
enhanced the mRNA expression and protein abundance of
Glut5, PAT1, and NHE3 in their jejunum versus control diet
(60% starch) [27].
ThepresenceofafunctionalGlut5isessentialforfructose
absorption and fructose-stimulated salt absorption in the
small intestine. These conclusions are based on studies
performed in Glut5 deﬁcient animals that were subjected to
a high-fructose diet. Results from these studies revealed that
increased dietary fructose (60%) caused severe small intesti-
nalmalabsorption, asillustratedbymassivedilation ofbowel
loops, speciﬁcally the cecum [42]. Furthermore, Glut5+/+
mice showed a sixfold increase in their blood fructose levels,
whereas Glut5−/− mice had no noticeable increase in their
blood fructose level even after ﬁve days on a high-fructose
diet [42]. Lastly, Glut5−/− mice developed hypotension after
5 days of being fed a high fructose diet, due to volume
depletion [42]. Taken together, these results strongly suggest
that Glut5 is essential for the absorption of fructose and in
conjunction with NHE3 and PAT1 play the central role in
fructose-stimulated salt absorption in the intestine.
7. EffectofIncreasedDietaryFructoseIntakeon
UrinarySaltExcretioninRatsand Mice
The fructose concentration in the lumen of the small
intestine directly reﬂects the amount of fructose present
in the diet and can range from almost zero to more than
30–40mM in humans or animals on a high-fructose diet.
The fructose concentration in the blood and kidney tubule
ﬁltrate is ∼2 orders of magnitude lower than the blood,
with values ranging between 50 and 500μM/liter in subjectsInternational Journal of Nephrology 5
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Figure 3: The role of fructose and Glut5 in fructose absorption and fructose-stimulated salt absorption in the small intestine. Luminal
fructose is predominantly absorbed via Glut5 action and stimulates PAT1 and NHE3, therefore enhancing salt absorption in the jejunum.
The stimulatory eﬀect of luminal fructose on salt absorption in jejunum was completely abrogated in Glut5 null mice (see [12]).
on normal- and high-fructose diets, respectively. Despite a
much lower fructose concentration in the kidney, there is
clear evidence which supports an important role for fructose
on salt absorption in the kidney proximal tubule. These
results demonstrated that a high-fructose diet signiﬁcantly
decreased the daily excretion of chloride and sodium in
the rat kidney while kidney function, including BUN and
serum creatinine and urine osmolality, remained unchanged
[13]. The stimulatory eﬀect of a high-fructose diet on salt
absorption in the kidney was also evident in wild-type mice.
In addition to its pivotal role in fructose-stimulated salt
absorption in jejunum, PAT1 also plays an important role
in enhanced kidney salt absorption in mice fed increased
dietary fructose. Recent observation in our laboratory indi-
cate that while sodium and chloride excretion rates in PAT1
wild and null mice are comparable on control diet, they are
signiﬁcantly increased in PAT1 null mice on high-fructose
diet (unpublished data). Kidney function and serum uric
acidremainednormalandcomparableinPAT+/+ andPAT−/−
mice on high-fructose diet. Figure 4 depicts the eﬀect of
increased dietary fructose intake on Glut5 and salt absorbing
transporters in the kidney proximal tubule.
8. Fructose-Induced Hypertension:Role of
NHE3,PAT1,andGlut5
Recent studies indicated that the development of fructose-
induced hypertension requires functional PAT1 and Glut5
in the intestine and kidney. These studies demonstrated that
PAT1+/+ mice on a high-fructose diet for 12 weeks developed
signiﬁcant increase in their blood pressure [13]. In contrast,
PAT1−/− mice failed to develop hypertension on a high-
fructose diet [13]. PAT1−/− mice displayed normal food
intake and weight gain on either control or high-fructose
diet versus PAT1+/+ mice. Both PAT1+/+ and PAT1−/− mice
showed comparable increase in plasma fructose on increased
dietary fructose regiment [13]. The role of intestinal Glut5
in fructose-stimulated salt absorption was dramatic: while
Glut5+/+ mice tolerated the high-fructose diet and developed
hypertension after 12 weeks, Glut5−/− mice developed
massive fructose malabsorption and became hypotensive
after only 5 days of augmented dietary fructose intake
[12]. Taken together, these results indicate that PAT1 and
Glut5 are essential for the generation of fructose-induced
hypertension.
9. Role of Gender in
Fructose-Induced Hypertension
Recent ﬁndings in our laboratory point to the role of gender
in the severity of fructose-induced hypertension. When fed
a high-fructose diet, male mice displayed a more severe
hypertension relative to female mice (personal observation).
It is intriguing to speculate that this eﬀect might be in
part related to the role of gender on the expression of salt
absorbing transporters in the kidney proximal tubule [12].
10. Role of SaltIntakein
Fructose-Induced Hypertension
If fructose stimulates salt absorption in the intestine and
kidney, then it is reasonable to ask whether varying the
amount of dietary salt has any impact on fructose-induced
hypertension. Studies in rats have conﬁrmed this speculation
by showing that high salt intake enhances and low salt intake
blunts the magnitude of fructose-induced hypertension6 International Journal of Nephrology
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Figure 4: Eﬀect of increased dietary fructose on Glut5 and salt-absorbing transporters in kidney proximal tubule. Increased dietary fructose
intake enhances the expression of Glut5 and increases the absorption of salt via NHE3 and PAT1 in the kidney proximal tubule (see [13]a n d
personal observation).
[20]. These studies are in agreement with observations
that fructose stimulates salt absorption in the intestine and
kidney [13], and alterations in the amount of dietary salt will
aﬀectthemagnitudeofsaltabsorptionfromtheintestineand
kidneywhichinturncanimpactthestateofsaltoverloadand
hypertension.
11. Role of VariousMonosaccharides in Salt
Absorption inthe IntestineandKidney
It has been known for a very long time that glucose enhances
sodium absorption in the small intestine via activation of
Na-Glucose transporter (SGLT1), which actually formed the
basis of the “oral rehydration solutions” adapted by the
World Health Organization. In humans, oral glucose intake
induces a slight and transient increase of blood pressure
[58]. However, that eﬀect is secondary to sympathetic
activation [58] and not due to salt overload. It has been
suggested that the consumption of excess sugar (glucose)-
sweetened beverages is associated with the development and
maintenance of obesity, which in turn can increase blood
pressure via multiple factors [59]. However, there is no data
indicating that increased dietary glucose intake increases
blood pressure by increasing salt absorption in both the
intestine and kidney.
Am a j o rd i ﬀerence between glucose and fructose metab-
olism is the fact that glucose absorption from the intestine
triggers insulin release whereas fructose absorption does not.
As a result of insulin release, the glucose concentration in the
blood remains normal. It is therefore unlikely that increased
glucose intake increases salt absorption in the kidney tubules
since the glucose concentration in the glomerular ﬁltrate
is normal. However, increased dietary fructose intake does
not stimulate insulin release, and fructose concentration in
the blood and glomerular ﬁltrate reaches levels 5–7 times
above normal in rodents on increased dietary fructose intake
[13, 42]. These diﬀerences might explain the increased salt
absorption in the kidney tubules of rats or mice on increased
dietary fructose intake [13].
12. HyperuricimiaDoesNot Play
a Major Role in the Generationof
Fructose-Induced Hypertension
The possible contribution of hyperuricemia in fructose-
induced hypertension has been the subject of several studies
and many speculations. Our studies in rats on high-fructose
diet for ﬁve weeks or in mice on high-fructose diet for
12 weeks did not demonstrate any elevation in serum uric
acid; although, they did show enhanced excretion of uric
acid in the urine [13]. These results clearly demonstrate
that serum uric acid is not causally linked to the gen-
eration of hypertension in fructose-induced hypertension.
Furthermore, it indicates that as long as kidney function
remainsstableelevateddietaryfructoseintakedoesnotcause
hyperuricemia. We speculate that the hyperuricemia that has
been reported in rodents on high-fructose diet (reviewed in
[22])is a secondaryphenomenon andresultsfrom decreased
kidney function (GFR) subsequent to hypertension [13].
13. Summary and Conclusions
Based on recent published reports and observations in our
laboratory we suggest that fructose-induced hypertension is
generated in large part by a state of salt overload resulting
from enhanced salt absorption in intestine and kidney. The
increase in dietary fructose intake stimulates salt absorptionInternational Journal of Nephrology 7
in the small intestine and kidney proximal tubule through
coordinated activation of PAT1, NHE3, and Glut5. We
propose that reducing dietary intake of fructose and salt, as
well as maneuvers aimed at inhibiting fructose absorption
in the intestine and kidney tubules, could have profound
beneﬁcial eﬀect on controlling blood pressure in patients
with metabolic syndrome.
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